TP53 and cancer: Notably, the HOXA5 promoter region is methylated in most p53-negative breast tumour specimens where a compromised HOXA5 function was shown to limit p53 expression, but also in other cancer entities a correlation between DNAm and HOXA5 expression has been described [30, 61].